These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 9159478

  • 1. Crystal structures of the free and liganded form of an esterolytic catalytic antibody.
    Wedemayer GJ, Wang LH, Patten PA, Schultz PG, Stevens RC.
    J Mol Biol; 1997 May 02; 268(2):390-400. PubMed ID: 9159478
    [Abstract] [Full Text] [Related]

  • 2. A structural basis for transition-state stabilization in antibody-catalyzed hydrolysis: crystal structures of an abzyme at 1. 8 A resolution.
    Kristensen O, Vassylyev DG, Tanaka F, Morikawa K, Fujii I.
    J Mol Biol; 1998 Aug 21; 281(3):501-11. PubMed ID: 9698565
    [Abstract] [Full Text] [Related]

  • 3. A comparison of the crystallographic structures of two catalytic antibodies with esterase activity.
    Buchbinder JL, Stephenson RC, Scanlan TS, Fletterick RJ.
    J Mol Biol; 1998 Oct 09; 282(5):1033-41. PubMed ID: 9753552
    [Abstract] [Full Text] [Related]

  • 4. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies.
    Ulrich HD, Schultz PG.
    J Mol Biol; 1998 Jan 09; 275(1):95-111. PubMed ID: 9451442
    [Abstract] [Full Text] [Related]

  • 5. Crystallographic and biochemical analysis of cocaine-degrading antibody 15A10.
    Larsen NA, de Prada P, Deng SX, Mittal A, Braskett M, Zhu X, Wilson IA, Landry DW.
    Biochemistry; 2004 Jun 29; 43(25):8067-76. PubMed ID: 15209502
    [Abstract] [Full Text] [Related]

  • 6. Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies.
    Charbonnier JB, Carpenter E, Gigant B, Golinelli-Pimpaneau B, Eshhar Z, Green BS, Knossow M.
    Proc Natl Acad Sci U S A; 1995 Dec 05; 92(25):11721-5. PubMed ID: 8524836
    [Abstract] [Full Text] [Related]

  • 7. Transition state docking: a probe for noncovalent catalysis in biological systems. Application to antibody-catalyzed ester hydrolysis.
    Tantillo DJ, Houk KN.
    J Comput Chem; 2002 Jan 15; 23(1):84-95. PubMed ID: 11913392
    [Abstract] [Full Text] [Related]

  • 8. Crystal structures of an enantioselective fab-fragment in free and complex forms.
    Parkkinen T, Nevanen TK, Koivula A, Rouvinen J.
    J Mol Biol; 2006 Mar 24; 357(2):471-80. PubMed ID: 16427081
    [Abstract] [Full Text] [Related]

  • 9. Mutational analysis of the affinity maturation of antibody 48G7.
    Yang PL, Schultz PG.
    J Mol Biol; 1999 Dec 17; 294(5):1191-201. PubMed ID: 10600377
    [Abstract] [Full Text] [Related]

  • 10. Structural basis for a disfavored elimination reaction in catalytic antibody 1D4.
    Larsen NA, Heine A, Crane L, Cravatt BF, Lerner RA, Wilson IA.
    J Mol Biol; 2001 Nov 16; 314(1):93-102. PubMed ID: 11724535
    [Abstract] [Full Text] [Related]

  • 11. Crossreactivity, efficiency and catalytic specificity of an esterase-like antibody.
    Gigant B, Charbonnier JB, Eshhar Z, Green BS, Knossow M.
    J Mol Biol; 1998 Dec 04; 284(3):741-50. PubMed ID: 9826512
    [Abstract] [Full Text] [Related]

  • 12. Direct hydroxide attack is a plausible mechanism for amidase antibody 43C9.
    Chong LT, Bandyopadhyay P, Scanlan TS, Kuntz ID, Kollman PA.
    J Comput Chem; 2003 Sep 04; 24(12):1371-7. PubMed ID: 12868101
    [Abstract] [Full Text] [Related]

  • 13. A comparative analysis of the immunological evolution of antibody 28B4.
    Yin J, Mundorff EC, Yang PL, Wendt KU, Hanway D, Stevens RC, Schultz PG.
    Biochemistry; 2001 Sep 11; 40(36):10764-73. PubMed ID: 11535051
    [Abstract] [Full Text] [Related]

  • 14. Conformational dynamics of complementarity-determining region H3 of an anti-dansyl Fv fragment in the presence of its hapten.
    Nakasako M, Oka T, Mashumo M, Takahashi H, Shimada I, Yamaguchi Y, Kato K, Arata Y.
    J Mol Biol; 2005 Aug 19; 351(3):627-40. PubMed ID: 16019026
    [Abstract] [Full Text] [Related]

  • 15. Structural insights into the evolution of an antibody combining site.
    Wedemayer GJ, Patten PA, Wang LH, Schultz PG, Stevens RC.
    Science; 1997 Jun 13; 276(5319):1665-9. PubMed ID: 9180069
    [Abstract] [Full Text] [Related]

  • 16. Evolution of catalytic antibody repertoire in autoimmune mice.
    Nishi Y.
    J Immunol Methods; 2002 Nov 01; 269(1-2):213-33. PubMed ID: 12379363
    [Abstract] [Full Text] [Related]

  • 17. Catalysis of decarboxylation by a preorganized heterogeneous microenvironment: crystal structures of abzyme 21D8.
    Hotta K, Lange H, Tantillo DJ, Houk KN, Hilvert D, Wilson IA.
    J Mol Biol; 2000 Oct 06; 302(5):1213-25. PubMed ID: 11183784
    [Abstract] [Full Text] [Related]

  • 18. High resolution crystal structures of the catalytic domain of human phenylalanine hydroxylase in its catalytically active Fe(II) form and binary complex with tetrahydrobiopterin.
    Andersen OA, Flatmark T, Hough E.
    J Mol Biol; 2001 Nov 23; 314(2):279-91. PubMed ID: 11718561
    [Abstract] [Full Text] [Related]

  • 19. Structural basis for antibody catalysis of a disfavored ring closure reaction.
    Gruber K, Zhou B, Houk KN, Lerner RA, Shevlin CG, Wilson IA.
    Biochemistry; 1999 Jun 01; 38(22):7062-74. PubMed ID: 10353817
    [Abstract] [Full Text] [Related]

  • 20. The crystal structure of enoyl-CoA hydratase complexed with octanoyl-CoA reveals the structural adaptations required for binding of a long chain fatty acid-CoA molecule.
    Engel CK, Kiema TR, Hiltunen JK, Wierenga RK.
    J Mol Biol; 1998 Feb 06; 275(5):847-59. PubMed ID: 9480773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.